Predicting Immunotherapy Outcomes: 6th Genomics Tumor Board Meeting

March 12, 2019

Lucence held the 6th National Genomics Tumor Board (GTB) meeting on 5th March 2019, at Mount Elizabeth Hospital for physicians from the public and private hospitals.

Our guest speaker, Dr. Joe Yeong from Department of Pathology, Singapore General Hospital and A*STAR Institute of Molecular Cell and Biology, presented his pioneering work on using quantitative multiplex immunohistochemistry to predict immunotherapy outcomes. We were also glad to have Dr. Jens Samol and Dr. Matthew Flook from Tan Tock Seng Hospital present patient cases for community discussion.


Dr. Jens Samol with Dr. Tan Min-Han in a discussion on the patient case presented.

Dr. Matthew Flook presenting a patient case for community learning and discussion.

The GTB is a regular educational forum organized by Lucence and supported by the Singapore Society of Oncology. It provides a platform for oncologists, pathologists, and geneticists to learn and share about genomic medicine. For information on the upcoming meetings in 2019, kindly send us your details through this contact form.

Need Help?